How many mg is 100 units of tirzepatide depends on your vial's concentration. At the most common 10 mg/ml concentration, 100 units (a full 1 ml insulin syringe) equals 10 mg of tirzepatide. If your vial is 5 mg/ml, the same full syringe equals 5 mg. At 20 mg/ml, 100 units equals 20 mg, which significantly exceeds the FDA-approved maximum of 15 mg per week. Always verify your vial concentration. Checkout this GLP-1 dose calculator for better insights.

Quick Answer Table: 100 Units of Tirzepatide to mg

100 units is a full 1 ml insulin syringe. The mg content varies dramatically by concentration.

Concentration

Volume (100 units)

mg of Tirzepatide

5 mg/ml

1.0 ml (full syringe)

5 mg

10 mg/ml (most common)

1.0 ml (full syringe)

10 mg

20 mg/ml

1.0 ml (full syringe)

20 mg (above FDA max)

Here is what to know up front about 100 units of tirzepatide mg conversion. A full 1 ml insulin syringe holds 100 units, but the mg dose in that full syringe depends entirely on concentration. At the most common 10 mg/ml concentration, 100 units delivers 10 mg, the fourth standard titration step. The full syringe tirzepatide draw is the most volume a single U100 1 ml insulin syringe can hold. The math follows FDA prescribing information. For broader context, see how many mg in a ml.

The Math: How We Calculated This

The formula for 100 units to mg tirzepatide conversion is:

mg = (units ÷ 100) × concentration (mg/ml)

Worked example at 10 mg/ml (most common):

100 units ÷ 100 = 1.0 ml (a full 1 ml syringe) 1.0 ml × 10 mg/ml = 10 mg

At 5 mg/ml: 100 ÷ 100 = 1.0 ml 1.0 ml × 5 mg/ml = 5 mg

At 20 mg/ml: 100 ÷ 100 = 1.0 ml 1.0 ml × 20 mg/ml = 20 mg (above FDA-approved 15 mg maximum)

A full 1 ml tirzepatide dose at the most common concentration delivers exactly 10 mg, one of the standard titration steps.

Why Concentration Determines the mg Dose

How much is in 100 units of tirzepatide depends on the vial concentration. The same full syringe can deliver 5 mg, 10 mg, or 20 mg depending on which compounding pharmacy made your vial.

This matters most at the 20 mg/ml concentration. Drawing a full syringe from a 20 mg/ml vial delivers 20 mg, which is well above the FDA-approved maximum of 15 mg per week. Patients on 20 mg/ml vials must draw 75 units (0.75 ml) for the 15 mg maximum dose, not the full 100 units.

For tirzepatide 100 units, the relationship between syringe fullness and mg dose changes completely with concentration. Always verify before drawing.

What Does a 10 mg Tirzepatide Dose Mean?

If you are using a 10 mg/ml vial and drawing tirzepatide 100 units, you are receiving 10 mg of tirzepatide. This is the fourth standard FDA-approved titration step, typically used during weeks 13 to 16 of therapy.

The 10 mg dose:

  • Is the fourth FDA-approved titration step (after 2.5, 5, and 7.5 mg)

  • Provides strong therapeutic effects in clinical trials

  • Often serves as a long-term maintenance dose without further escalation

  • Is the most common reason patients switch from 10 mg/ml to 20 mg/ml vials (because 100 units fills a full syringe)

Many patients reach 10 mg and stay at this dose for long-term therapy. Some escalate to 12.5 mg or 15 mg for stronger effects.

Common Concentrations and 100 Units

For full conversion charts, see the compounded tirzepatide dosage guide.

At 5 mg/ml concentration: 100 units = 5 mg tirzepatide. This is the second standard FDA titration step. A full 1 ml syringe delivers a standard dose.

At 10 mg/ml concentration (most common): 100 units = 10 mg tirzepatide. This is the fourth standard FDA titration step. A full 1 ml syringe delivers a standard dose.

At 20 mg/ml concentration: 100 units = 20 mg tirzepatide. This significantly exceeds the FDA-approved maximum of 15 mg per week. Do not draw a full syringe from a 20 mg/ml vial unless specifically prescribed.

Safety Note for 100 Units at 20 mg/ml

Drawing a full 1 ml syringe from a 20 mg/ml vial delivers 20 mg of tirzepatide, which is 5 mg above the FDA-approved maximum. This is a 33% overdose relative to the approved maximum and has not been studied in Phase 3 clinical trials for safety or efficacy.

If you have a 20 mg/ml vial, your maximum FDA-approved draw is 75 units (15 mg). Drawing 100 units would result in a 20 mg dose, which has limited long-term safety data and requires direct physician supervision if intentional.

Frequently Asked Questions

At 10 mg/ml, the most common compounded concentration, 100 units (a full 1 ml syringe) of tirzepatide equals 10 mg. This is the fourth standard FDA-approved titration step, typically used during weeks 13 to 16 of therapy.

The answer depends on concentration. At 5 mg/ml, a full 1 ml syringe is 5 mg. At 10 mg/ml (most common), it is 10 mg. At 20 mg/ml, it is 20 mg, which exceeds the FDA-approved maximum of 15 mg per week.

At 20 mg/ml, 100 units of tirzepatide equals 20 mg, which is well above the FDA-approved maximum of 15 mg per week. Do not draw a full syringe from a 20 mg/ml vial unless your physician specifically prescribed this off-label dose.

Yes. The 10 mg dose is the fourth FDA-approved titration step (after 2.5, 5, and 7.5 mg). Many patients find their target therapeutic effect at 10 mg and stay on this dose long-term. Some escalate to 12.5 mg or the 15 mg maximum.

Drawing a full syringe is safe if the concentration aligns with your prescribed dose. At 10 mg/ml, a full syringe is 10 mg (a standard dose). At 20 mg/ml, a full syringe is 20 mg (above the FDA maximum). Always confirm the dose matches your prescription.

At 10 mg/ml, 10 mg = 100 units (full syringe). At 20 mg/ml, 10 mg = 50 units (half syringe). Continuing to draw 100 units after the switch would deliver 20 mg, double your intended dose. Always recalculate when switching concentrations.